The European Medicines Agency has validated the Type II Variation marketing authorization application for Datroway as monotherapy for the ...

Saphnelo has been approved in the European Union, EU, for subcutaneous self-administration as a pre-filled pen for adult ...

AstraZeneca’s AZN first-quarter 2023 core earnings of 96 cents per American depositary share (ADS) beat the Zacks Consensus Estimate of 86 cents and our model estimate of 85 cents. Core earnings of $1 ...

The move would onshore production of its rare disease products at an existing facility in Frederick and build a clinical research drug factory in Gaithersburg.

AstraZeneca PLC (NASDAQ:AZN) operates across global healthcare markets through advanced research pathways, biopharmaceutical ...

Currently, the S&P 500 and many sectors are outperforming the healthcare sector, presenting an opportunity to explore assets within this sector during the current period of apathy towards it.

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca announced it will expand the savings programs for its entire US inhaled respiratory portfolio, helping eligible patients pay no more than $35 per month ...

AstraZeneca recently bundled its COVID-19 vaccine and antibody treatment into a separate division. But there’s a chance that the new unit might not stay with it for long. The British drugmaker is ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp., AstraZeneca PLC ...

The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, after getting approval from the city of Frederick’s Planning Commission. The ...